key: cord-1028507-s6ksas20
authors: Vlasova, Anastasia N; Takanashi, Sayaka; Miyazaki, Ayako; Rajashekara, Gireesh; Saif, Linda J
title: How the gut microbiome regulates host immune responses to viral vaccines
date: 2019-08-03
journal: Curr Opin Virol
DOI: 10.1016/j.coviro.2019.05.001
sha: e1fadb50206234f3cc8bc1750506068f8597baa3
doc_id: 1028507
cord_uid: s6ksas20

The co-evolution of the microbiota and immune system has forged a mutually beneficial relationship. This relationship allows the host to maintain the balance between active immunity to pathogens and vaccines and tolerance to self-antigens and food antigens. In children living in low-income and middle-income countries, undernourishment and repetitive gastrointestinal infections are associated with the failure of oral vaccines. Intestinal dysbiosis associated with these environmental influences, as well as some host-related factors, compromises immune responses and negatively impacts vaccine efficacy. To understand how immune responses to viral vaccines can be optimally modulated, mechanistic studies of the relationship between the microbiome, host genetics, viral infections and the development and function of the immune system are needed. We discuss the potential role of the microbiome in modulating vaccine responses in the context of a growing understanding of the relationship between the gastrointestinal microbiota, host related factors (including histo-blood group antigens) and resident immune cell populations.

Anastasia N Vlasova 1 , Sayaka Takanashi 1,2 , Ayako Miyazaki 3 , Gireesh Rajashekara 1 and Linda J Saif 1

The co-evolution of the microbiota and immune system has forged a mutually beneficial relationship. This relationship allows the host to maintain the balance between active immunity to pathogens and vaccines and tolerance to self-antigens and food antigens. In children living in low-income and middle-income countries, undernourishment and repetitive gastrointestinal infections are associated with the failure of oral vaccines. Intestinal dysbiosis associated with these environmental influences, as well as some host-related factors, compromises immune responses and negatively impacts vaccine efficacy. To understand how immune responses to viral vaccines can be optimally modulated, mechanistic studies of the relationship between the microbiome, host genetics, viral infections and the development and function of the immune system are needed. We discuss the potential role of the microbiome in modulating vaccine responses in the context of a growing understanding of the relationship between the gastrointestinal microbiota, host related factors (including histo-blood group antigens) and resident immune cell populations.

Numerous factors influence vaccine efficacy including nutrition, sex, age, genetics, and health status and these vary greatly between low-income and middle-income (LMIC) and high-income (HIC) countries as reviewed elsewhere [1 ] . Immune responses to oral cholera, poliovirus (PV) and rotavirus (RV) vaccines are significantly lower in children from LMICs than those of children from HICs [2] . For example, only 58% of Nicaraguan and 46% of Bangladeshi children respond to oral RV vaccine while the efficacy of the vaccine in Finland is over 98% [3] [4] [5] . The poor immune responsiveness to vaccination characteristic for LMICs is multifactorial and is associated with host-associated (genetics and commensal microbiota), pathogen-associated (genetic diversity) and environmental factors [6-8,9 ,10,11 ] ( Figure 1 ).

The diverse communities of microbes that colonize the gut and other body surfaces (microbiome) have coevolved with their host species in a symbiotic relationship [12 ] . The microbiome as a whole or its individual members play important roles in the development and functionality of the immune system [13 ] . Colonization occurs mostly during birth and soon after, and the microbiome becomes mature by 2 years of age. Until then, the microbial composition is highly variable and can be easily perturbed by various environmental exposures [14 ,15 ] .

The environmental influences of early life that affect the microbiome and can therefore alter vaccine efficacy include diet, delivery method (vaginal versus caesarean section), and hygiene (clean versus unsanitary environment) [16] [17] [18] . Additionally, breastfeeding is known to modulate vaccine responses in infants via altering the microbiome composition and maternal antibody interference with the development of the active (post-vaccine) immune response [19] . High levels of neutralizing antibodies (Ab) in the breast milk of mothers from LMICs were shown to correlate with lower seroconversion rates in their children, suggestive of maternal Ab interference with the 'take' of oral RV vaccines. However, restriction of breastfeeding did not enhance the IgA immune response to oral RV vaccines in children [20 ,21] .

can result from enteric dysbiosis and EED [1 ,22,23] . In agreement with these observations, celiac disease patients have decreased seroconversion to hepatitis B vaccine [24 ] . Also, chronic infections with many viruses including human cytomegalovirus and human immunodeficiency virus induce immune suppression decreasing the effectiveness of many vaccines [25] . However studies on the interactions between the resident virome and host immune function are scarce [26, 27] . Collectively, these observations emphasize that 'healthy' gut microbiome is the key element that maintains intestinal homeostasis critical for optimal vaccine performance.

Since the gut microbiota is intimately linked with immune system development, it is likely that immune responses to all vaccines are modulated by distinct microbial profiles [28] . Systemically immunized GF and antibiotic treated conventional mice showed decreased serum Ab and T-cell responses compared to the age-matched conventional animals [29 ] . The introduction of the normal microbiota to the GF mice improved their immune responsiveness following immunization [29 ] . In addition, the nasal microbiota also contributes to immune responses to live influenza vaccine, by modifying antiviral IgA Ab production [30] . However, comprehensive studies that directly evaluate how the gut microbiota, as a whole or the individual major microbial taxa, influence immune responses to vaccines are limited.

In a recent study, transplantation of dysbiotic microbiota from stunted Nicaraguan infants decreased numbers of intestinal and systemic effector T cells that coincided with decreased protection against human RV (HRV) challenge in vaccinated human microbiota-associated (HMA) piglets [31] . Numerically decreased IgA and IgG Ab responses were also observed in the dysbiotic HMA piglets further emphasizing the suboptimal HRV vaccine performance associated with intestinal dysbiosis. Importantly this study emphasizes that dysbiotic microbiome is the primary factor associated with the decreased immune responses, because unlike in infant donors, EED was not evident in the HMA piglets. Further, these results and our previous data [32] suggest that specific pathological microbial signatures can be maintained after dysbiosis was induced and can even be transferrable to another host, negatively affecting their immunity. The latter indicates that maternal dysbiosis can be transferred to infants and leading to health and developmental setbacks in early life.

Further, Lactobacillus rhamnosus strain GG (LGG), in a dose-dependent manner, enhanced innate, cytokine, and cellular T cell responses in HMA piglets vaccinated with HRV vaccine [33]. However, the enhanced immune Environmental factors: Further, microbiota-associated intestinal inflammation can alter RA levels [60 ] affecting the balance between immunoregulatory and inflammatory T cells, emphasizing that the interactions between gut microbiota and vitamin A are bidirectional in nature. Zinc is another micronutrient that is often deficient in low income settings and affects the efficiency of oral vaccines. Mice on a zinc-deficient diet had decreased Th1 and IgG responses to a Hepatitis B vaccine [61] . While zinc deficiency is linked with poor vaccine responses and can modify the composition of the microbiota [62] , direct competition between intestinal bacteria and the host for zinc may explain why oral supplementation of zinc does not compensate for its deficiency.

Collectively, these recent studies suggest that while nutrient imbalance and dysbiotic microbiome induce negative effects on host health, immunity and intestinal barrier, their synergistic interactions are implicated in the pathogenesis of severe childhood PCM.

The significance of the microbial-immune interactions is best exemplified by the fact that the immune system of germ-free (GF) mice and pigs is anatomically and functionally immature [63,64 ,65,66 ] , while colonization of the GF animals with commensal microbiota or even individual probiotic species corrects these defects [67 ,68,69 ,70-72] . Further, individual commensal microorganisms and their metabolites induce maturation of the intestinal and systemic immune systems [71, 73] and modulate cellular signaling as summarized by Valdez et al.

[1 ]. Besides induction of immune maturation, microbiota regulates the state of hypo-responsiveness against commensals, self-antigens, and food antigens [72, 74 ] .

Immune cells are equipped with various innate immune receptors [including Toll-like receptors (TLR) and nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs)] to recognize and interact with microbial cells. Our recent study comparing TLR expression profiles in GF and conventional newborn and young pigs demonstrated that exposure to commensal microbiota has a greater influence on TLR mRNA expression than age [75] . TLRs on epithelial and dendritic cells (that can extend their dendrites through the epithelial layer) come into direct contact with luminal microorganisms [76] . These TLR-microbial interactions induce production of anti-microbial peptides and secretory (polymeric) IgA by epithelial and immune cells, respectively [77, 78] . Binding of anti-microbial peptides and IgA to the mucus layer that separates commensal bacteria from the apical surface of intestinal epithelial cells (IECs) constrains the topography, composition, and functions of commensal bacteria, thereby preventing inflammatory reactions [79] .

Intestinal dysbiosis associated with inadequate diets, antibiotic use, and enteric pathogens cause local inflammation, altering intestinal barrier function. This results in aberrant interactions between immune cells and microbes, which triggers systemic inflammation and autoimmunity, as reported in type 1 diabetes [80] . Further, numerous mouse models deficient in TLRs/NLRs and/or their signaling adaptor proteins (such as MyD88) develop intestinal dysbiosis [81] which leads to the development of various diseases [82] . The latter illustrates the role of genetic factors in dysbiosis development. Often transfer of this 'dysbiotic microbiota' into naïve hosts is sufficient to induce disease and reproduce its pathogenesis [32,83,84 ]. Therefore, this complex two-way communication plays a critical role in intestinal health and disease.

Finally, although it is recognized that the gut microbiota composition influences systemic immunity, the exact mechanisms of how the gut bacteria exert the immunomodulatory effects at systemic immune sites remain largely unknown [85] . Two alternative theories postulate that these effects can be achieved either via secretion and systemic circulation of microbiota-derived soluble factors [86] or via migration of the activated lamina propria lymphocytes into the periphery [87] .

ABO/H and Lewis family antigens are recognized as receptors by numerous pathogens, including, noroviruses (NoVs), RVs, and coronaviruses [88] [89] [90] [91] [92] [93] [94] and the severity of RV disease is reportedly higher in children with blood group A [95] . Several recent studies demonstrated that host histo-blood group antigen (HBGA) phenotypes impact incidence of all-cause diarrhea [96] and the efficacy of oral RV vaccines by altering susceptibility to RV in unvaccinated children [97] . Lewis A phenotype was shown to be a restriction factor for RotaTeq and Rotarix vaccine-take [98] .

The polymorphic HBGAs, including the ABO/H, secretor and Lewis families, are found on red blood cells, mucosal epithelia [99] and in biologic fluids (saliva, intestinal contents, milk, and blood) of secretor individuals [100] .

The nonsecretor homozygous genotype in fucosyltransferase 2 (FUT2; occurring due to natural polymorphisms) is associated with resistance to NoV genogroup II and Helicobacter pylori infections that vary with ethnicities [101, 102] . Distinct HBGA phenotypes also result in variable binding specificities of innate immune factors such as the galectins [103] or differential profiles of circulating natural Abs [104] . Different HBGAs are also observed in animals, including pigs that express A and H antigens (that share high identity with those of humans), which may facilitate zoonotic and reverse zoonotic infections [105] . Further, certain lactobacilli were shown to bind HBGAs [106, 107] while some enteric bacteria [108] produce HBGA-like substances suggesting that such bacteria can directly bind some enteric viruses [108] . Collectively, these data suggest that commensal and pathogenic microorganisms have evolved that exploit human and animal HBGAs as cellular receptors.

Further, recent data showed that healthy subjects with different HBGA possessed distinct profiles of fecal microbiota [109 ,110] . The nonsecretor status was also linked to the gut microbiome alterations in patients with inflammatory bowel disease [111] . These provide examples of the influence of host genetics on the intestinal microbiome composition and suggests that HBGA-mediated modulation of the intestinal microbiome may contribute to the observed variations in the vaccine efficacy. Thus, future vaccine trials should account for HBGA status or offer optimized multivalent vaccines that can perform equally well in hosts with different HBGAs.

LMICs. Alterations in the intestinal microbiota are currently being recognized as a leading factor associated with vaccine failures, and their effects are being evaluated in human clinical trials. Supplementation with specific strains of probiotics has been shown to have modulatory effects on intestinal and systemic immune responses in animal models providing the basis for studies with vaccines in humans [72, 73, 112, 113] (Figure 2 ). However, most clinical studies conducted in children and adults generated results that varied by age, antigen, type of Ab response, and probiotic strain [19] . The mechanisms that influence vaccine performance include direct or indirect immunomodulatory actions of probiotics that have yet to be fully evaluated experimentally. Direct effects include alteration of the pathogen-associated molecular patterns presented to the gut-associated lymphoid tissue. Indirect effects can be mediated by changes to the gut microbiota and immunoactive microbial metabolites such as SCFA [114] . Probiotics also affect the functions of IECs through modulation of tight junctions, increasing mucin and defensin production, inducing antimicrobial and heat shock protein production, interfering with pathogenic organisms, and modulating signaling pathways and cell survival [115] [116] [117] [118] . Certain probiotic strains have been shown to enhance Ab responses to oral vaccines against RV [35, [119] [120] [121] , Salmonella [122] , PV [123] , and Vibrio cholerae [124] in human volunteers, and this effect was observed after a short period (1-5 weeks) of probiotic treatment. The positive effect of probiotics on immune responses was also seen in parenterally administered vaccines against diphtheria, tetanus, Haemophilus influenzae type B, and hepatitis B [125] [126] [127] in infants after a sixmonth period. However, no mechanistic explanations for the observed effects or detailed microbiome analysis were available from these studies.

Despite extensive research and plentiful novel data, there still is a need for improved understanding of the role of microbiota in the immune responses to vaccines. To establish causal relationships between the composition of microbiota and responses to oral and parenteral vaccines, additional clinical and experimental studies are needed. Large-scale studies correlating the effects of diets, probiotics, and antibiotics with pre-vaccine microbial diversity and post-vaccine immune responses will identify environment and microbiota-driven effects. Adoptive transfer of the dysbiotic microbiomes to GF animals would define the function and reversibility of the 

Nothing declared. 

Pulendran B: Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc Natl Acad Sci U S A 2014, 111:12300-12306. A review that highlights how 'systems biology' approach can aid in identification of molecular signatures predictive of vaccination outcomes and how such findings can be used to to reprogram suboptimal immune systems.

Brown EM, Sadarangani M, Finlay BB: The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol 2013, 14:660-667. Complex interactions and co-influences between the gut microbiota and immune system.

Jamieson AM: Influence of the microbiome on response to vaccination. Hum Vaccines Immunother 2015, 11:2329-2331. A short review that discusses molecular and immunological mechanisms of vaccine hyporesponsiveness and the role of gut microbiota in it.

14. 

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

Host-gut microbiota metabolic interactions

Normalizing microbiota-induced retinoic acid deficiency stimulates protective CD8(+) T cell-mediated immunity in colorectal cancer

A recent study revealing co-regulatory interactions between vitamin A, gut microbiota and immune cells

Gestational zinc deficiency impairs humoral and cellular immune responses to hepatitis B vaccination in offspring mice

Zinc competition among the intestinal microbiota

Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota

Antibody repertoire development in fetal and neonatal piglets. VIII. Colonization is required for newborn piglets to make serum antibodies to T-dependent and type 2 T-independent antigens

One of several classical studies demonstrating the importance of the intestinal microbiota for the immune system development

Interactions between the microbiota and the immune system

Commensal bacteria calibrate the activation threshold of innate antiviral immunity

Another important study describing how the intestinal microbiota controls antiviral immunity

Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis

The authors showed that bectaerial peptidoglycan is essential and sufficient to induce the genesis of intestinal lymphoid folliles in mice via NOD1 (nucleotide-binding oligomerization domain containing 1) signailing

Patterns of early gut colonization shape future immune responses of the host

Gut immune maturation depends on colonization with a host-specific microbiota

The maturation of the immune system is achieved more efficiently after colonization with host-specific microbiota

Differential effects of Escherichia coli Nissle and Lactobacillus rhamnosus strain GG on human rotavirus binding, infection, and B cell immunity

Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses

Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs

Comparison of probiotic Lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species

Intestinal IgA production and its role in host-microbe interaction

Tissuespecific mRNA expression profiles of porcine Toll-like receptors at different ages in germ-free and conventional pigs

Unique transcompartmental bridge: antigen-presenting cells sampling across endothelial and mucosal barriers

Role of the gut microbiota in immunity and inflammatory disease

The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis

The gastrointestinal mucus system in health and disease

Dysbiosis of the gut microbiota in disease

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism

Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy

Noroviruses bind to human ABO, Lewis, and secretor histoblood group antigens: identification of 4 distinct strainspecific patterns

Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner

Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens

Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals

Association of histo-blood group antigens with susceptibility to norovirus infection may be strain-specific rather than genogroup dependent

Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histoblood group antibodies

El-Taweel AN: ABO blood grouping in Egyptian children with rotavirus gastroenteritis

Effects of child and maternal Histo Blood Group Antigen status on symptomatic and asymptomatic enteric infections in early childhood

Histoblood group antigen phenotype determines susceptibility to genotype-specific rotavirus infections and impacts measures of rotavirus vaccine efficacy

The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children

ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution

ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world

A natural history of FUT2 polymorphism in humans

Sequence and expression of a candidate for the human secretor blood group alpha(1,2)fucosyltransferase gene (FUT2)

Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype

Innate immune lectins kill bacteria expressing blood group antigen

Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens

ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior

Lactic acid bacteria (LAB) bind to human B-or H-antigens expressed on intestinal mucosa

Lactobacilli binding human A-antigen expressed in intestinal mucosa

Histo-blood group antigenlike substances of human enteric bacteria as specific adsorbents for human noroviruses

Relationships between gastrointestinal microbiota and blood group antigens

A blood group secretor status is associated with less diversity at higher order taxa; and the presence of blood group A antigens in the secretor subjects leads to expansion families of bacteria within the gut

Association between the ABO blood group and the human intestinal microbiota composition

Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype

Vaccine adjuvant properties of probiotic bacteria

Vaccines-Basel

Control of antiviral immunity by pattern recognition and the microbiome

Probiotics-host communication: modulation of signaling pathways in the intestine

Neish AS: Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation

Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells

In vivo gut transcriptome responses to Lactobacillus rhamnosus GG and Lactobacillus acidophilus in neonatal gnotobiotic piglets

Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG

Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model

Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine

Modulation of humoral immune response through probiotic intake

Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination

Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial

Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines

Effect of probiotics on vaccine antibody responses in infancy-a randomized placebo-controlled double-blind trial